(Q53364717)

13 May 2018

title

Summary of the International Consensus Symposium on Advances in the Diagnosis, Treatment and Prophylaxis and Cytomegalovirus Infection. (English)

1 reference

13 May 2018

0 references

van der Meer JT

1

1 reference

13 May 2018

Drew WL

2

1 reference

13 May 2018

Bowden RA

3

1 reference

13 May 2018

Galasso GJ

4

1 reference

13 May 2018

Griffiths PD

5

1 reference

13 May 2018

Jabs DA

6

1 reference

13 May 2018

Katlama C

7

1 reference

13 May 2018

Spector SA

8

1 reference

13 May 2018

Whitley RJ

9

1 reference

13 May 2018

publication date

1 November 1996

1 reference

13 May 2018

published in

Antiviral Research

1 reference

13 May 2018

volume

32

1 reference

13 May 2018

issue

3

1 reference

13 May 2018

page(s)

119-140

1 reference

13 May 2018

Prospective randomized trial of efficacy of ganciclovir versus that of anti-cytomegalovirus (CMV) immunoglobulin to prevent CMV disease in CMV-seropositive heart transplant recipients treated with OKT3.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

Foscarnet for treatment of cytomegalovirus infections in bone marrow transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

Failure of prophylactic ganciclovir to prevent cytomegalovirus disease in recipients of lung transplants

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

Single amino acid changes in the DNA polymerase confer foscarnet resistance and slow-growth phenotype, while mutations in the UL97-encoded phosphotransferase confer ganciclovir resistance in three double-resistant human cytomegalovirus strains recov

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

Treatment of AIDS-associated gastrointestinal cytomegalovirus infection with foscarnet and ganciclovir: a randomized comparison

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

Detection of ganciclovir resistance mutations quantitation of cytomegalovirus (CMV) DNA in leukocytes of patients with fatal disseminated CMV disease

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

Transfusion-transmitted cytomegalovirus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

Cytomegalovirus (CMV)-Specific Intravenous Immunoglobulin for the Prevention of Primary CMV Infection and Disease after Marrow Transplant

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

Cytomegalovirus immune globulin and seronegative blood products to prevent primary cytomegalovirus infection after marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

Natural history of untreated cytomegalovirus retinitis

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

Dramatic interstrain differences in the replication of human cytomegalovirus in SCID-hu mice

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

The predictive value of cytomegalovirus retinitis for cytomegalovirus encephalitis in acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

Human cytomegalovirus clinical isolates carry at least 19 genes not found in laboratory strains.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

9-(1,3-Dihydroxy-2-propoxymethyl)guanine (ganciclovir) in the treatment of cytomegalovirus gastrointestinal disease with the acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

Cytomegalovirus infection of the central nervous system in patients with AIDS: diagnosis by DNA amplification from cerebrospinal fluid

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

Cytomegalovirus infection in homosexual men. Relationship to sexual practices, antibody to human immunodeficiency virus, and cell-mediated immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

Prophylaxis of primary cytomegalovirus disease in renal transplant recipients. A trial of ganciclovir vs immunoglobulin

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

Molecular analysis of the immune response to human cytomegalovirus glycoprotein B (gB). II. Low gB-specific T and B cell responses are associated with expression of certain HLA-DR alleles

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

High dose intravitreal foscarnet in the treatment of cytomegalovirus retinitis in AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

Ganciclovir treatment of gastrointestinal infections caused by cytomegalovirus in patients with AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

Ganciclovir treatment of cytomegalovirus colitis in AIDS: a randomized, double-blind, placebo-controlled multicenter study

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

Concurrent use of ganciclovir and foscarnet to treat cytomegalovirus infection in AIDS patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

Enhancement of Murine Cytomegalovirus Infection during Graft-vs.-Host Reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

Oral ganciclovir as maintenance treatment for cytomegalovirus retinitis in patients with AIDS. Syntex Cooperative Oral Ganciclovir Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

Prevalence of Cytomegalovirus Infection in Homosexual Men

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

Multiple infections by cytomegalovirus in patients with acquired immunodeficiency syndrome: documentation by Southern blot hybridization

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

Cytomegalovirus pneumonia after bone marrow transplantation successfully treated with the combination of ganciclovir and high-dose intravenous immune globulin

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

Local therapy for cytomegalovirus retinopathy.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

Ganciclovir/foscarnet for cytomegalovirus meningoencephalitis in AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

The outcome of congenital cytomegalovirus infection in relation to maternal antibody status

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

Longitudinal analysis of cytomegalovirus load in renal transplant recipients using a quantitative polymerase chain reaction: correlation with disease

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

Increased efficacy of ganciclovir in combination with foscarnet against cytomegalovirus and herpes simplex virus type 2 in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

Gastrointestinal cytomegalovirus disease

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

Ganciclovir prophylaxis to prevent cytomegalovirus disease after allogeneic marrow transplant

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

Rapid diagnosis of cytomegalovirus infection in immunocompromised patients by detection of early antigen fluorescent foci

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

Symptomatic cytomegalovirus infection in seropositive kidney recipients: reinfection with donor virus rather than reactivation of recipient virus

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

Is cytomegalovirus interstitial pneumonitis in transplant recipients an immunopathological condition?

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

Low frequency maintenance ganciclovir for cytomegalovirus retinitis

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

Cytomegalovirus infection in sex partners: evidence for sexual transmission

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

Use of intravitreal ganciclovir (dihydroxy propoxymethyl guanine) for cytomegalovirus retinitis in a patient with AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

Virus infections after transplantation in man. Brief review

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

The Transplanted Kidney as a Source of Cytomegalovirus Infection

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

A dose-ranging study of daily maintenance intravenous foscarnet therapy for cytomegalovirus retinitis in AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

Randomized phase I trial of two different combination foscarnet and ganciclovir chronic maintenance therapy regimens for AIDS patients with cytomegalovirus retinitis: AIDS clinical Trials Group Protocol 151

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

Failure of antiviral therapy for acquired immunodeficiency syndrome-related cytomegalovirus myelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

Randomized prospective trial of ganciclovir maintenance therapy for cytomegalovirus retinitis

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

Risk/benefit ratio of perioperative OKT3 in cardiac transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

Intravitreal cidofovir (HPMPC) treatment of cytomegalovirus retinitis in patients with acquired immune deficiency syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

Cytomegalovirus isolate resistant to ganciclovir and foscarnet from a marrow transplant patient

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

Primate cytomegalovirus assembly: evidence that DNA packaging occurs subsequent to B capsid assembly

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

An adenovirus recombinant that expresses the human cytomegalovirus major envelope glycoprotein and induces neutralizing antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

Treatment of cytomegalovirus retinitis with an intraocular sustained-release ganciclovir implant. A randomized controlled clinical trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

Diagnosis and Treatment of Cytomegalovirus Disease in Transplant Patients Based on Gastrointestinal Tract Manifestations

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

Increase in severity of graft versus host disease by cytomegalovirus

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

Identification of the major late human cytomegalovirus matrix protein pp65 as a target antigen for CD8+ virus-specific cytotoxic T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

A Controlled Trial of Ganciclovir to Prevent Cytomegalovirus Disease after Heart Transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

Risk factors for cytomegalovirus infection after human marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

Cytomegalovirus in the lungs of patients with AIDS. Respiratory pathogen or passenger?

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

AIDS-associated cytomegalovirus infection mimicking central nervous system tumors: a diagnostic challenge.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

A Randomized, Controlled Trial of Foscarnet in the Treatment of Cytomegalovirus Retinitis in Patients with AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

Potent antiviral activity of an antisense oligonucleotide complementary to the intron-exon boundary of human cytomegalovirus genes UL36 and UL37

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

A prospective comparison of molecular diagnostic techniques for the early detection of cytomegalovirus in liver transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

Combined and alternating ganciclovir and foscarnet in acute and maintenance therapy of human immunodeficiency virus-related cytomegalovirus encephalitis refractory to ganciclovir alone. A case report and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

Vaccines for varicella-zoster virus and cytomegalovirus: recent progress

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

CMV retinitis: ganciclovir/monoclonal antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

OKT3 treatment for allograft rejection is a risk factor for cytomegalovirus disease in liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

Cytomegalovirus infection--an etiological factor for rejection? A prospective study in 242 renal transplant patients

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

Antibody response to human cytomegalovirus glycoproteins gB and gH after natural infection in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

Characterization of two different human cytomegalovirus glycoproteins which are targets for virus neutralizing antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

Efficacy of cytomegalovirus immunoglobulin in marrow transplant recipients with cytomegalovirus pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

Treatment of cytomegalovirus pneumonia with ganciclovir and intravenous cytomegalovirus immunoglobulin in patients with bone marrow transplants

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

Treatment of cytomegalovirus pneumonia with 9-[2-hydroxy-1-(hydroxymethyl)ethoxymethyl]guanine and high-dose corticosteroids

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

Antimicrobial strategies in the care of organ transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

Discrete gastrointestinal mass lesions caused by cytomegalovirus in patients with AIDS: report of three cases and review

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

Double resistance to ganciclovir and foscarnet of four human cytomegalovirus strains recovered from AIDS patients

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

Immune predispositions for cytomegalovirus retinitis in AIDS. The HNRC Group

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

Activity of 9-[2-hydroxy-1-(hydroxymethyl)ethoxymethyl]guanine in the treatment of cytomegalovirus pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

Infections with cytomegalovirus and other herpesviruses in 121 liver transplant recipients: transmission by donated organ and the effect of OKT3 antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

The role of pretransplant immunity in protection from cytomegalovirus disease following renal transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

PCR detection of cytomegalovirus: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

Detection of IgM antibody to cytomegalovirus and rapid diagnosis of this virus infection by the shell vial assay

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

Human cytomegalovirus structural proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

Identification of Multiple Cytomegalovirus Strains in Homosexual Men with Acquired Immunodeficiency Syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

Oral ganciclovir for the prevention of cytomegalovirus disease in persons with AIDS. Roche Cooperative Oral Ganciclovir Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

A randomized, controlled study of intravenous ganciclovir therapy for cytomegalovirus peripheral retinitis in patients with AIDS. AIDS Clinical Trials Group and Cytomegalovirus Cooperative Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

Mortality in patients with the acquired immunodeficiency syndrome treated with either foscarnet or ganciclovir for cytomegalovirus retinitis

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

Immunomodulatory and antimicrobial efficacy of intravenous immunoglobulin in bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

Murine cytomegalovirus-associated pneumonitis in the lungs free of the virus

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

Rapid immunodiagnosis of active cytomegalovirus infection by monoclonal antibody staining of blood leucocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

Cytomegalovirus colitis and oesophageal ulceration in the context of AIDS: clinical manifestations and preliminary report of treatment with Foscarnet (phosphonoformate).

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

Transmission of cytomegalovirus by renal allograft demonstrated by restriction enzyme analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

Cytomegalovirus esophagitis in AIDS: a prospective evaluation of clinical response to ganciclovir therapy, relapse rate, and long-term outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

Ganciclovir prophylaxis of cytomegalovirus infection and disease in allogeneic bone marrow transplant recipients. Results of a placebo-controlled, double-blind trial

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

Randomised comparison of ganciclovir and high-dose acyclovir for long-term cytomegalovirus prophylaxis in liver-transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

Diagnosis of human cytomegalovirus central nervous system disease in AIDS patients by DNA amplification from cerebrospinal fluid

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

Enhancement of Mouse Cytomegalovirus Infection During Host-Versus-Graft Reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

Prevention and treatment of cytomegalovirus pneumonia in transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2896%2901006-6

7 January 2021

10.1016/S0166-3542(96)01006-6

Identifiers

DOI

1 reference

13 May 2018

PubMed ID

8955508

1 reference

13 May 2018